Artivion, Inc. (AORT) — Fair Value Analysis
Base-case fair value (P50): $19.81 · Current price: $23.35 · Verdict: Overvalued
The Verdict on AORT
Based on our comprehensive Monte Carlo simulations, ARTIVION INC (AORT) is currently assessed as Fairly Valued. While the stock trades at $23.35, our median fair value (P50) stands at $19.81. This implies a -15.2% difference, indicating that at its current price, AORT is trading above its intrinsic value derived from thousands of forward-looking scenarios. Despite this implied downside, the broader range of probabilistic outcomes leads to a "Fairly Valued" verdict, suggesting the market price generally aligns with the expected risk-adjusted returns over time, though some downward pressure might be warranted.
How AORT stacks up against Healthcare
AORT's operational and financial health is categorized as "average" relative to its Healthcare sector peers. This average quality tier plays a significant role in anchoring the Monte Carlo simulation's median fair value at $19.81. Companies with average quality tiers typically don't command premium valuations or deep discounts without significant fundamental shifts. Therefore, an average quality tier combined with a current price of $23.35 that suggests a -15.2% divergence from the median fair value points to a balanced market view, preventing a definitive "overvalued" or "undervalued" call at this juncture.
What this means for investors
For investors considering ARTIVION INC, the "Fairly Valued" verdict, coupled with the -15.2% implied downside compared to our median fair value of $19.81 against the current $23.35, suggests a cautious approach. While the stock isn't definitively overvalued, the data indicates it's not presenting a clear value opportunity either. Understanding the full range of probabilistic outcomes, including the bear and bull cases, is crucial for making informed decisions. Sign up for a free FairCurve account to see the full bear/bull distribution and track AORT's fair value as new fundamentals are released.
Frequently Asked Questions
Is AORT overvalued or undervalued right now?
Based on our Monte Carlo simulations, ARTIVION INC (AORT) is currently assessed as fairly valued. The median fair value (P50) is $19.81, which is below its current trading price of $23.35, suggesting an implied downside.
What is the bear case and bull case for AORT?
The full Monte Carlo simulation provides a probabilistic distribution for AORT's fair value, including specific bear (P10) and bull (P90) case price targets, along with the probability of upside. This detailed analysis is exclusively available to FairCurve account holders.
How does FairCurve calculate AORT's fair value?
FairCurve calculates AORT's fair value using advanced Monte Carlo simulations. This involves running thousands of forward-looking scenarios to model various financial outcomes and probabilities, resulting in a robust intrinsic value range.
How can I track AORT's fair value as it changes?
You can easily track AORT's updated fair value by adding it to a free FairCurve watchlist. FairCurve provides daily fair value updates and instantly re-evaluates the stock when new financial data, such as earnings reports, are released.